Shantell Laketa Heiber

Array ( [id] => 1533778 [patent_doc_number] => 06488936 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Immunogenic composition of interleukin-12 (IL-12), alum, herpes simplex viral (HSV) antigen, and method thereof' [patent_app_type] => B1 [patent_app_number] => 09/247635 [patent_app_country] => US [patent_app_date] => 1999-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6464 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/488/06488936.pdf [firstpage_image] =>[orig_patent_app_number] => 09247635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4376222 [patent_doc_number] => 06277380 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Measles virus mutant antigen' [patent_app_type] => 1 [patent_app_number] => 9/230944 [patent_app_country] => US [patent_app_date] => 1999-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23659 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277380.pdf [firstpage_image] =>[orig_patent_app_number] => 230944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4350254 [patent_doc_number] => 06200577 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Anti-herpesviral agents and assays therefor' [patent_app_type] => 1 [patent_app_number] => 9/230421 [patent_app_country] => US [patent_app_date] => 1999-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 12503 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200577.pdf [firstpage_image] =>[orig_patent_app_number] => 230421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1535275 [patent_doc_number] => 06337074 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-08 [patent_title] => 'Anti-herpesviral agent' [patent_app_type] => B1 [patent_app_number] => 09/230405 [patent_app_country] => US [patent_app_date] => 1999-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14547 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/337/06337074.pdf [firstpage_image] =>[orig_patent_app_number] => 09230405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4244562 [patent_doc_number] => 06207165 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Polynucleotide formula against porcine reproductive and respiratory pathologies' [patent_app_type] => 1 [patent_app_number] => 9/232468 [patent_app_country] => US [patent_app_date] => 1999-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 7875 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207165.pdf [firstpage_image] =>[orig_patent_app_number] => 232468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4244576 [patent_doc_number] => 06207166 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Polynucleotide formulation against pathologies of the horse' [patent_app_type] => 1 [patent_app_number] => 9/232478 [patent_app_country] => US [patent_app_date] => 1999-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 7187 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207166.pdf [firstpage_image] =>[orig_patent_app_number] => 232478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4241310 [patent_doc_number] => 06221362 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Avian polynucleotide formula' [patent_app_type] => 1 [patent_app_number] => 9/232479 [patent_app_country] => US [patent_app_date] => 1999-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 6554 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221362.pdf [firstpage_image] =>[orig_patent_app_number] => 232479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440532 [patent_doc_number] => 06335016 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-01 [patent_title] => 'Chicken embryo lethal orphan (CELO) virus' [patent_app_type] => B1 [patent_app_number] => 09/171461 [patent_app_country] => US [patent_app_date] => 1999-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 46491 [patent_no_of_claims] => 166 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/335/06335016.pdf [firstpage_image] =>[orig_patent_app_number] => 09171461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177625 [patent_doc_number] => 06149922 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Vaccine adjuvant and vaccine' [patent_app_type] => 1 [patent_app_number] => 9/221339 [patent_app_country] => US [patent_app_date] => 1998-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 52 [patent_no_of_words] => 13988 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 285 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/149/06149922.pdf [firstpage_image] =>[orig_patent_app_number] => 221339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4254324 [patent_doc_number] => 06258363 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use' [patent_app_type] => 1 [patent_app_number] => 9/219337 [patent_app_country] => US [patent_app_date] => 1998-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5491 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258363.pdf [firstpage_image] =>[orig_patent_app_number] => 219337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4100744 [patent_doc_number] => 06100079 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Method for treating biopolymers, microorganisms or materials by using more than one type of magnetic particles' [patent_app_type] => 1 [patent_app_number] => 9/125581 [patent_app_country] => US [patent_app_date] => 1998-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5036 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100079.pdf [firstpage_image] =>[orig_patent_app_number] => 125581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177937 [patent_doc_number] => 06159477 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus' [patent_app_type] => 1 [patent_app_number] => 9/213053 [patent_app_country] => US [patent_app_date] => 1998-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 15 [patent_no_of_words] => 12316 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159477.pdf [firstpage_image] =>[orig_patent_app_number] => 213053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4286555 [patent_doc_number] => 06180108 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Vectors having terminal repeat sequence of Epstein-Barr virus' [patent_app_type] => 1 [patent_app_number] => 9/209915 [patent_app_country] => US [patent_app_date] => 1998-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2620 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180108.pdf [firstpage_image] =>[orig_patent_app_number] => 209915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 91672 [patent_doc_number] => 07732129 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-06-08 [patent_title] => 'Method for the production and purification of adenoviral vectors' [patent_app_type] => utility [patent_app_number] => 09/203078 [patent_app_country] => US [patent_app_date] => 1998-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 60 [patent_no_of_words] => 54921 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732129.pdf [firstpage_image] =>[orig_patent_app_number] => 09203078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4293037 [patent_doc_number] => 06184025 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Viral isolates associated with multiple sclerosis' [patent_app_type] => 1 [patent_app_number] => 9/200990 [patent_app_country] => US [patent_app_date] => 1998-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 23 [patent_no_of_words] => 16267 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184025.pdf [firstpage_image] =>[orig_patent_app_number] => 200990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4212513 [patent_doc_number] => 06110663 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Methods for detecting, titering, and determining susceptibility to papillomavirus' [patent_app_type] => 1 [patent_app_number] => 9/190433 [patent_app_country] => US [patent_app_date] => 1998-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5632 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110663.pdf [firstpage_image] =>[orig_patent_app_number] => 190433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1253025 [patent_doc_number] => 06670118 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-30 [patent_title] => 'Method for treating papillomavirus infections' [patent_app_type] => B2 [patent_app_number] => 09/189172 [patent_app_country] => US [patent_app_date] => 1998-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3438 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/670/06670118.pdf [firstpage_image] =>[orig_patent_app_number] => 09189172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4415737 [patent_doc_number] => 06194143 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Substrates for human cytomegalovirus protease' [patent_app_type] => 1 [patent_app_number] => 9/171590 [patent_app_country] => US [patent_app_date] => 1998-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11729 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 288 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194143.pdf [firstpage_image] =>[orig_patent_app_number] => 171590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4266464 [patent_doc_number] => 06322795 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses' [patent_app_type] => 1 [patent_app_number] => 9/000266 [patent_app_country] => US [patent_app_date] => 1998-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9804 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/322/06322795.pdf [firstpage_image] =>[orig_patent_app_number] => 000266 [rel_patent_id] =>[rel_patent_doc_number] =>)